According to Takara Bio's latest financial reports the company's current revenue (TTM ) is S$0.39 Billion. In 2023 the company made a revenue of S$0.44 Billion a decrease over the revenue in the year 2022 that were of S$0.83 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | S$0.39 B | -11.11% |
2023 | S$0.44 B | -46.26% |
2022 | S$0.83 B | 11.08% |
2021 | S$0.75 B | 51.98% |
2020 | S$0.49 B | 16.04% |
2019 | S$0.42 B | -3.37% |
2018 | S$0.44 B | 18.04% |
2017 | S$0.37 B | -5.58% |
2016 | S$0.39 B | 14.87% |
2015 | S$0.34 B | 12.5% |
2014 | S$0.30 B | 4.66% |
2013 | S$0.29 B | -2.48% |
2012 | S$0.30 B | -3.85% |
2011 | S$0.31 B | 12% |
2010 | S$0.27 B | -1.6% |
2009 | S$0.28 B |